Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation

Experimental Cell Research

Volumn 319, Issue 20, 2013, Pages 3238-3250

  Karki, Rajendra ^a,c   Kim, Seong Bin ^b   Kim, Dong Wook ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Jeollanamdo Development Institute for Korean Traditional Medicine   (South Korea)

^c Mokpo National University   (South Korea)

Author keywords

Magnolol; Restenosis; Stress fibers; VSMC migration

Indexed keywords

BETA1 INTEGRIN; COLLAGEN TYPE 1; GELATIN; GLYCEROL; MAGNOLOL; MATRIX METALLOPROTEINASE; MYOSIN LIGHT CHAIN; PROTEIN CDC42; PROTEIN TYROSINE KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPE; IMMUNOHISTOCHEMISTRY; MOLECULE; NEOINTIMA; NONHUMAN; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; SPECTROFLUOROMETRY; STRESS FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

RATTUS;

EID: 84887189130     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.07.016     Document Type: Article

References (63)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
2. Goetze S., Xi X.P., Kawano Y., Kawano H., Fleck E., Hsueh W.A., Law R.E. TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 1999, 33:183-189.
3. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ. Res. 2007, 100:607-621.
4. Ruef J., Hu Z.Y., Yin L.Y., Wu Y., Hanson S.R., Kelly A.B., Harker L.A., Rao G.N., Runge M.S., Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. Circ. Res. 1997, 81:24-33.
5. Mugabe B.E., Yaghini F.A., Song C.Y., Buharalioglu C.K., Waters C.M., Malik K.U. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitrogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation. J. Pharmacol. Exp. Ther. 2010, 332:116-124.
6. Bell L., Madri J.A. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ. Res. 1989, 65:1057-1065.
7. Ferns G.A.A., Raines E.W., Sprugel K.H., Motani A.S., Reidy M.A., Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253:1129-1132.
8. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res. 2003, 92:27-39.
9. Menezes G., Miron-Mendoza M., Ho C.H., Jiang H., Grinnell F. Oncogenic Ras-transformed human fibroblasts exhibit differential changes in contraction and migration in 3D collagen matrices. Exp. Cell. Res. 2008, 314:3081-3091.
10. Glass C., Witztum J.L. Atherosclerosis. The road ahead. Cell 2001, 104:503-516.
11. Yamamoto M., Yamamoto K., Noumura T. Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype. Exp. Cell Res. 1993, 204:121-129.
12. Hedin U., Bottger B.A., Forsberg E., Johansson S., Thyberg J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J. Cell Biol. 1988, 107:307-319.
13. Liu M.W., Roubin G.S., King S.B. Restenosis after coronary angioplasty. Circulation 1989, 79:1374-1387.
14. Ross R. Polypeptide growth factors and atherosclerosis. Trends Cardiovasc. Med. 1991, 1:277-282.
15. Geng Y., Libby P. Progression of atheroma: a struggle between death and procreation. Atheroscler. Thromb. Vasc. Biol. 2002, 22:1370-1380.
16. Osherov A.B., Gotha L., Cheema A.N., Qiang B., Strauss B.H. Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy. Cardiovasc. Res. 2011, 91:16-26.
17. Nelson P.R., Yamamura S., Kent K.C. Extracellular matrix proteins are potent agonists of human smooth muscle cell migration. J. Vasc. Surg. 1996, 24:25-33.
18. Wight T. The extracellular matrix and atherosclerosis. Curr. Opinion Lipidol. 1995, 6:326-334.
19. Plenz G., Deng M.C., Robenek H., Volker W. Vascular collagens: spotlight on the role of type VIII collagen in atherogenesis. Atherosclerosis 2003, 166:1-11.
20. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2002, 2:91-100.
21. Hynes R. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
22. Zheng Y. Dbl family guanine nucleotide exchange factors. Trends Biochem. Sci. 2001, 26:724-732.
23. Sellers J., Spudich J.A., Sheetz M.P. Light chain phosphorylation regulates the movement of smooth muscle myosin on actin filaments. J. Cell Biol. 1985, 101:1897-1902.
24. +2 channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci. 1990, 47:1153-1161.
25. Chen S., Chang Y.L., Wang D.L., Cheng J.J. Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells. Br. J. Pharmacol. 2006, 148:226-232.
26. Chen Y., Lin S.J., Chen J.W., Ku H.H., Chen Y.L. Magnolol attenuates VCAM-1 expression in vitro in TNF-α treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br. J. Pharmacol. 2002, 135:37-47.
27. Karki R., Jeon E.R., Kim D.W. Magnoliae Cortex inhibits intimal thickening of carotid artery through modulation of proliferation and migration of vascular smooth muscle cells. Food Chem. Toxicol. 2012, 50:634-640.
28. Karki R., Ho O.M., Kim D.W. Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-κB activation in vascular smooth muscle cells. Biochim. Biophys. Acta 2013, 1830:2619-2628.
29. Karki R., Jeon E.R., Kim D.W. Nelumbo nucifera leaf extract inhibits neointimal hyperplasia through modulation of smooth muscle cell proliferation and migration. Nutrition 2013, 29:268-275.
30. Yoon J., Lee Y.J., Kim J.S., Kang D.G., Lee H.S. Betulinic acid inhibits high glucose induced vascular smooth muscle cells proliferation and migration. J. Cell. Biochem. 2011, 111:1501-1511.
31. Huang C., Huang W.J., Wang S.J., Wu P.H., Wu W.B. Litebamine, a phenanthrene alkaloid from the wood of Litsea cubeba, inhibits rat smooth muscle cell adhesion and migration on collagen. Eur. J. Pharmacol. 2008, 596:25-31.
32. Han Y., Hu W.Y., Piano M., de Lanerolle P. Regulation of myosin light chain kinase expression by angiotensin II in hypertension. Am. J. Hypertens. 2008, 21:860-865.
33. Thomas R., Kim J., Revelo-Penafiel M.P., Angel R., Dawson D.W., Lowy A.M. The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia. Gut 2008, 57:1555-1560.
34. Xavier L.L., Viola G.G., Ferraz A.C., Da Cunha C., Deonizio J.M., Netto C.A., Achaval M. A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Brain Res. Brain Res. Protoc. 2005, 16:58-64.
35. Bendeck M., Zempo N., Clowes A.W., Galardy R.E., Reidy M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 1994, 75:539-545.
36. Wang Z., Castresana M.R., Newman W.H. NF-kappaB is required for TNF-alpha directed smooth muscle cell migration. FEBS Lett. 2001, 508:360-364.
37. McLean G., Carragher N.O., Avizienyte E., Evans J., Brunton V.G., Frame M.C. The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat. Rev. Cancer 2005, 5:505-515.
38. Salazar E., Rozengurt E. Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J. Biol. Chem. 2001, 276:17788-17795.
39. Kim L.T., Yamada K.M. The regulation of expression of integrin receptors. Proc. Soc. Exp. Biol. Med. 1997, 214:123-131.
40. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: the road taken. Science 1995, 268:233-239.
41. Casey R.C., Skubitz A.P. CD44 and β1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin. Exp. Metastasis 2000, 18:67-75.
42. Kishi H., Mikawa T., Seto M., Sasaki Y., Kanayasu-Toyoda T., Yamaguchi T., Imamura M., Ito M., Karaki H., Bao J., Nakamura A., Ishikawa R., Kohama K. Stable transfectants of smooth muscle cell line lacking the expression of myosin light chain kinase and their characterization with respect to the actomyosin system. J. Biol. Chem. 2000, 275:1414-1420.
43. Pauly R.R., Passaniti A., Bilato C., Monticone R., Cheng L., Papadopoulos N., Gluzband Y.A., Smith L., Weinstein C., Lakatta E.G., Crow M.T. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ. Res. 1994, 75:41-54.
44. Grotendorst G.R., Seppa H.E.J., Kleinman H.K., Martin G.R. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 1981, 78:3669-3672.
45. Liotta L.A., Steeg P.A., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336.
46. Kuzuya M., Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J. Atheroscler. Thromb. 2003, 10:275-282.
47. Kim H., Bae S.J., Kim D.W., Kim B.K., Lee S.B., Lee U.S. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alphainduced vascular smooth muscle cells. Int. Immunopharmacol. 2007, 7:1083-1091.
48. Miyazawa K., Kikuchi S., Fukuyama J., Hamano S., Ujiie A. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 1995, 118:213-221.
49. Guarda E., Katwa L.C., Campbell S.E., Tanner M.A., Webel R.M., Laughlin H., Jenkins S., Myers P.R. Extracellular matrix collagen synthesis and degradation following coronary balloon angioplasty. J. Mol. Cell. Cardiol. 1996, 28:699-706.
50. Moiseeva E. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc. Res. 2001, 52:372-386.
51. Parsons J. Focal adhesion kinase: the first ten years. J. Cell Sci. 2003, 116:1409-1416.
52. Clark E.A., King W.G., Brugge J.S., Symons M., Hynes R.O. Integrin-mediated signals regulated by members of the Rho family of GTPases. J. Cell Biol. 1998, 142:573-586.
53. Hotulainen P., Lappalainen P. Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J. Cell Biol. 2006, 173:383-394.
54. Castellano F., Montcourrier P., Guillemot J.C., Gouin E., Machesky L., Cossart P., Chavrier P. Inducible recruitment of Cdc42 or WASP to a cell-surface receptor triggers actin polymerization and filopodium formation. Curr. Biol. 1999, 9:351-360.
55. Rolli-Derkinderen M., Toumaniantz G., Pacaud P., Loirand G. RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration. Mol. Cell. Biol. 2010, 30:4786-4796.
56. Strauss B., Chisholm R.J., Keeley F.W., Gotlieb A.I., Logan R.A., Armstrong P.W. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res. 1994, 75:650-658.
57. Skinner M., Raines E.W., Ross R. Dynamic expression of α1β1 and α2β1 integrin receptors by human vascular smooth muscle cells: α2β1 integrin is required for chemotaxis across type I collagen coated membranes. Am. J. Pathol. 1994, 145:1070-1081.
58. Bass R., Wagstaff L., Ravenhill L., Ellis V. Binding of extracellular maspin to beta1 integrins inhibits vascular smooth muscle cell migration. J. Biol. Chem. 2009, 284:27712-27720.
59. Wang H., Tanaka H., Qin X., Zhao T., Ye L.H., Okagaki T., Katayama T., Nakamura A., Ishikawa R., Thatcher S.E., Wright G.L., Kohama K. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction. Am. J. Physiol. Heart. Circ. Physiol. 2008, 294:2060-2068.
60. Bhadriraju K., Yang M., Alom R.S., Pirone D., Tan J., Chen C.S. Activation of ROCK by RhoA is regulated by cell adhesion, shape, and cytoskeletal tension. Exp. Cell Res. 2007, 313:3616-3623.
61. Huang J., Zhang J., Pathak A., Li J., Stouffer G.A. Perivascular delivery of blebbistatin reduces neointimal hyperplasia after carotid injury in the mouse. J. Pharmacol. Exp. Ther. 2011, 336:116-126.
62. Ou H., Chou F.P., Sheu W.H., Hsu S.L., Lee W.J. Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells. Arch. Toxicol. 2007, 81:421-432.
63. Ho J., Hong C.Y. Cardiovascular protection of magnolol: cell-type specificity and dose related effects. J. Biomed. Sci. 2012, 31:70.